Andersen, Jesper B.

Cholangiocarcinoma 2020: the next horizon in mechanisms and management

Banales, J. M., Marin, J. J. G., Lamarca, A., Rodrigues, P. M., Khan, S. A., Roberts, L. R., Cardinale, V., Carpino, G., Andersen, J. B., Braconi, C., et al. (2020) · Nature Reviews Gastroenterology & Hepatology

Cholangiocarcinoma and Gallbladder Cancer StudiesPediatric Hepatobiliary Diseases and Treatments

Cited by 2,411

Common Molecular Subtypes Among Asian Hepatocellular Carcinoma and Cholangiocarcinoma

Chaisaingmongkol, J., Budhu, A., Dang, H., Rabibhadana, S., Pupacdi, B., Kwon, S. M., Forgues, M., Pomyen, Y., Bhudhisawasdi, V., Lertprasertsuke, N., et al. (2017) · Cancer Cell

Cholangiocarcinoma and Gallbladder Cancer StudiesHepatocellular Carcinoma Treatment and Prognosis

Cited by 434

Mutations in isocitrate dehydrogenase 1 and 2 occur frequently in intrahepatic cholangiocarcinomas and share hypermethylation targets with glioblastomas

Wang, P., Dong, Q., Zhang, C., Kuan, P.-F., Liu, Y., Jeck, W. R., Andersen, J. B., Jiang, W., Savich, G. L., Tan, T.-X., et al. (2013) · Oncogene

Cholangiocarcinoma and Gallbladder Cancer StudiesPediatric Hepatobiliary Diseases and Treatments

Cited by 399

p53-Dependent Nestin Regulation Links Tumor Suppression to Cellular Plasticity in Liver Cancer

Tschaharganeh, D. F., Xue, W., Calvisi, D. F., Evert, M., Michurina, T. V., Dow, L. E., Banito, A., Katz, S. F., Kastenhuber, E. R., Weissmueller, S., et al. (2014) · Cell

Cancer-related Molecular PathwaysLiver physiology and pathology

Cited by 227

Beyond Post hoc Explanations: A Comprehensive Framework for Accountable AI in Medical Imaging Through Transparency, Interpretability, and Explainability

Singh, Y., Hathaway, Q. A., Keishing, V., Salehi, S., Wei, Y., Horvat, N., Vera-Garcia, D. V., Choudhary, A., Mula Kh, A., Quaia, E., et al. (2025) · Bioengineering

Explainable Artificial Intelligence (XAI)Artificial Intelligence in Healthcare and Education

Cited by 72

DNMT1 is a required genomic regulator for murine liver histogenesis and regeneration

Kaji, K., Factor, V. M., Andersen, J. B., Durkin, M. E., Tomokuni, A., Marquardt, J. U., Matter, M. S., Hoang, T., Conner, E. A., & Thorgeirsson, S. S. (2016) · Hepatology

Liver physiology and pathologyEpigenetics and DNA Methylation

Cited by 61

Dual-initiation promoters with intertwined canonical and TCT/TOP transcription start sites diversify transcript processing

Nepal, C., Hadzhiev, Y., Balwierz, P., Tarifeño-Saldivia, E., Cardenas, R., Wragg, J. W., Suzuki, A.-M., Carninci, P., Peers, B., Lenhard, B., et al. (2020) · Nature Communications

Genomics and Chromatin DynamicsRNA Research and Splicing

Cited by 52

Alternative promoters in CpG depleted regions are prevalently associated with epigenetic misregulation of liver cancer transcriptomes

Nepal, C., & Andersen, J. B. (2023) · Nature Communications

Epigenetics and DNA MethylationGenomics and Chromatin Dynamics

Cited by 39

Transcriptional, post-transcriptional and chromatin-associated regulation of pri-miRNAs, pre-miRNAs and moRNAs

Nepal, C., Coolen, M., Hadzhiev, Y., Cussigh, D., Mydel, P., Steen, V. M., Carninci, P., Andersen, J. B., Bally-Cuif, L., Müller, F., et al. (2016) · Nucleic Acids Research

MicroRNA in disease regulationGenomics and Chromatin Dynamics

Cited by 35

Deep learning-based uncertainty quantification for quality assurance in hepatobiliary imaging-based techniques

Singh, Y., Andersen, J. B., Hathaway, Q., Venkatesh, S. K., Gores, G. J., & Erickson, B. (2025) · Oncotarget

AI in cancer detectionRadiomics and Machine Learning in Medical Imaging

Cited by 8